Global Newborn Screening Test Market Size, Trends, and Analysis- Forecasts To 2026

The results analyzed by GME suggested that the market for Global Newborn Screening Testwill grow with a CAGR value of 10.2 percent, to reach xx billion USD by 2026. The growth of the market is expected to be driven by the rising number of newborn cases with congenital disease and increasing awareness of CCHD screening from 2021 to 2026.

Browse 159 Market Data Tables and 119 Figures spread through 189 Pages and in-depth TOC on "Newborn Screening Test Market – Forecast to 2026" https://www.globalmarketestimates.com/market-report/global-newborn-screening-test-market-2597

By Type of Test (Dry Blood Spot, Hearing Screen Test, Critical Congenital Heart Disease (CCHD)), By Technology (Electrophoresis, Tandem Mass Spectrometry, DNA Assays, Pulse Oximetry, Enzyme Based Assays), By Product (Reagents & Assay Kits, Instruments), By Region (North America, Asia Pacific, CSA, Europe, and the Middle East and Africa); End-User Landscape, Company Market Share Analysis & Competitor Analysis

Key Market Insights

The launch of new and innovative screening technologies to stimulate market growth

Growing diagnostic imaging practices for neonatal screening will help the market expand significantly from 2021 to 2026.
As of 2020, technology-based tandem mass spectrometry will grow at the highest CAGR over the projected timeframe.
The dry blood segment is anticipated to hold the largest share in the market over the predicted timeframe.
Covidien Plc., Bio-Rad Laboratories, Masimo Corporation, Natus, Medical, GE Lifesciences, AB SCIEX, Agilent Technologies, Waters Corporation, Trivitron, Healthcare, and PerkinElmer Inc, among others are the major players competing in this market.

Browse the Report @ https://www.globalmarketestimates.com/market-report/global-newborn-screening-test-market-2597

Type of Test Outlook (Revenue, USD Billion, 2021-2026)